Éthics of scientific publishing
“Medicina Paliativa” adheres to international ethics guidelines, and understands that the authors comply with the ethical responsibilities defined by the International Committee of Medical Journal Editors.
Please click on the following links to know more about ethical considerations in scientific publishing: www.publicationethics.org and http://www.icmje.org/recommendations/
Peer review
This journal operates a double-blind review process. The Editor performs an initial assessment of the manuscripts to ensure suitability to the Journal’s objectives. If positive, every manuscript is usually sent to a minimum of two independent reviewers to assess the scientific quality of the submitted paper. The Editor is responsible for the final decision regarding the acceptance or rejection of any manuscripts for publication.
Double-blind review
This journal uses a double-blind review approach, which means the both authors and reviewers are anonymous concerning the review process. Because of this, please submit your information in compliance with the manuscript submission guidelines for authors.
Human and animal rights
f the work involves the use of human subjects, the author must ensure that the work described was carried out in accordance with The Code of Ethics of the WHO (Declaration of Helsinki) for experiments involving humans. The manuscript must be in accordance with the ICMJE Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations in terms of sex, age, and ethnicity as per said recommendations.
Authors should state in the manuscript that an informed consent was obtained for experimentation from all human subjects under study. The privacy rights of human subjects must always be observed.
Animal experiments must comply with the ARRIVE Guidelines , and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments , or the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978). The authors must clearly state in the manuscript that the above guidelines were complied with. The sex of animals must also be indicated and, where appropriate, the influence (or association) of sex on (or with) the study results.
Conflicts of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.
Furthermore, any scholarships, awards or aids related to the manuscript should be specified in the conflicts of interest statement by the authors, and described in the cover letter using the template available both in the website’s general information and submission platform.
If there are no conflicts of interest to declare, the following should be specified: “Conflicts of interest: none”. This summary statement will be published within the article, if the manuscript is eventually accepted.
Use of inclusive language
Medicina Paliativa wants to contribute to the promotion of egalitarian policies by
encouraging the use of inclusive language in texts:
Discriminatory expressions should be
avoided, and collective terms encouraged (for instance, use of “their” rather
than his or her) in addition to any resources that may ensure the path to
effective equality.
Similarly, study reviews should
avoid all discrimination based on race, gender, nationality, ethnicity, or sexual,
political or religious preference.
For further
information please refer to the United Nations Guidelines for gender-inclusive
language in English (https://www.un.org/en/gender-inclusive-language/guidelines.shtml).
Sex and gender in research
Manuscripts
submitted for review and potential publication in the journal Medicina
Paliativa must avoid gender stereotypes and biases.
Authors must report whether gender was
considered in the design and conduction of research and data analysis so that
potential differences may be identified and/or biases avoided.
In this regard, the following is required:
- Sample
composition by sex.
- Results
broken down by sex.
- Analysis
of differences within each sex.
For further information please see the
document “Gender in research”.
Originality and plagiarism policy
Submission of an article implies that the work described has not been published previously, that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright holder. For verification, the article may be checked for originality using the service Crossref Similarity Check.
Clinical trial results
In accordance to recommendations issued by the International Committee of Medical Journal Editors, the Journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (for instance, at investors’ meetings) is discouraged, as it may jeopardize consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.
Description of randomized clinical trials
Randomized clinical trials must be reported according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram illustrating the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal, and completion, as well as a detailed description of the randomization procedure. Both the checklist and a template flow diagram are available from the CONSORT website.
Registration of clinical trials
For publication in this journal, clinical trials must be included in a public trials registry, as recommended by the International Committee of Medical Journal Editors (ICMJE). Trials must be registered at or before the onset of patient enrollment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups thereof to one or more health-related interventions to evaluate their effects. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related parameters obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those where the assignment of medical interventions is not dependent on the researcher) do not require registration.
Copyright and author rights
In the article submission form authors will be asked to complete a “publishing agreement” form.
Author rights
As an author, you or your empleyer or institution have certain rights to reuse your work.
Open access
“Medicina Paliativa” is an Open Access journal, with an embargo period of 12 months, which means that all its contents are freely available without charge to users or their institutions. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without prior permission from the publisher or author, in accordance with the BOAI definition of Open Access. Works may be reused in the terms established by the Creative Commons 4.0 (CC BY-NC-ND) license. Use of materials under said Creative Commons license will be subjected to authorization by the SECPAL, who owns the articles.
This journal has no publication fees. The Society that owns the Journal finances publication costs.
Informed consent and patient data
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the article. Should an author wish to include case details or other personal information or images of patients or any other individuals in an Inspira Network publication, appropriate consents, permissions and releases must be obtained. The author must retain all written consents, and sending copies to the Journal is not required. Only if specifically requested by the Journal in case of exceptional circumstances (for example, if a legal issue arises), the author will provide copies of the consents or evidence that such consents were duly obtained.
Manuscript submission
Our manuscript submission system will guide you stepwise through the process of entering data concerning your article and uploading files. The system will create a summary with all the files that make up the manuscript in order to conduct the peer-review process. The author for correspondence will receive information regarding their manuscript review process via e-mail.
Submit your article
Manuscripts must be submitted via the following site: http://gestormedpal.inspiranetwork.com